XML 44 R32.htm IDEA: XBRL DOCUMENT v3.5.0.2
Note A - Organization and Summary of Significant Accounting Policies (Details Textual)
$ / shares in Units, € in Millions
12 Months Ended
Mar. 19, 2015
shares
Jun. 30, 2016
USD ($)
$ / shares
shares
Jun. 30, 2015
USD ($)
$ / shares
shares
Jun. 30, 2016
EUR (€)
shares
Jun. 30, 2016
USD ($)
shares
Fair Value, Inputs, Level 1 [Member]          
Fair Value, Net Asset (Liability)     $ 0   $ 0
Fair Value, Inputs, Level 3 [Member]          
Fair Value, Net Asset (Liability)     $ 0   $ 0
Employee Stock Option [Member]          
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares   0 151,000    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate   0.00%      
Restricted Stock [Member] | 2009 Omnibus Stock Incentive Plan [Member] | Board of Directors and Management Members [Member] | Minimum [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period   0 years      
Restricted Stock [Member] | 2009 Omnibus Stock Incentive Plan [Member] | Board of Directors and Management Members [Member] | Maximum [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period   5 years      
Restricted Stock [Member] | 2009 Omnibus Stock Incentive Plan [Member] | Board of Directors and Management Members [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period 3 years        
Restricted Stock [Member] | 2009 Omnibus Stock Incentive Plan [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares   $ 9.86      
Restricted Stock [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number | shares     93,866 193,012 193,012
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options         $ 2,300,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition   1 year 219 days      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares   $ 9.86 $ 5.51    
2009 Omnibus Stock Incentive Plan [Member] | Board of Directors and Management Members [Member]          
Stock Issued During Period, Shares, Restricted Stock Award, Gross | shares 105,000 208,000      
2009 Omnibus Stock Incentive Plan [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares        
Minimum [Member]          
Property, Plant and Equipment, Useful Life   1 year      
Maximum [Member]          
Property, Plant and Equipment, Useful Life   39 years      
Foreign Exchange Contract [Member]          
Derivative, Notional Amount       € 16.8 19,000,000
Derivative, Remaining Maturity   1 year 60 days      
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Beta Alanine Raw Material Sale Customers [Member]          
Concentration Risk, Percentage   14.60% 26.00%    
Accounts Receivable [Member] | Customer Concentration Risk [Member]          
Concentration Risk, Percentage   61.10% 25.80%    
Liability for Uncertainty in Income Taxes, Current     $ 0   0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares   0 0    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value   $ 0 $ 0    
Foreign Currency Contract, Asset, Fair Value Disclosure     474,000   $ 250,000
Impairment of Long-Lived Assets to be Disposed of   0 417,000    
Royalty and Licensing Revenue   21,800,000 9,100,000    
Royalty Expense   865,000 806,000    
Research and Development Expense   1,100,000 1,100,000    
Advertising Expense   334,000 $ 69,000    
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount   $ (193,000)      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares   0 0    
Concentration of Risk Number of Major Customers   2